The effect of social deprivation on the dynamic of SARS-CoV-2 infection in France: a population-based analysis

被引:44
|
作者
Vandentorren, Stephanie [1 ,2 ]
Smaili, Sabira [1 ]
Chatignoux, Edouard [1 ]
Maurel, Marine [3 ]
Alleaume, Caroline [1 ]
Neufcourt, Lola [3 ]
Kelly-Irving, Michelle [3 ,4 ]
Delpierre, Cyrille [3 ]
机构
[1] Sante Publ France, F-94415 St Maurice, France
[2] Univ Bordeaux, INSERM UMR 1219, Bordeaux Populat Hlth, Bordeaux, France
[3] Univ Toulouse III Paul Sabatier, INSERM, CERPOP UMR 1295, Toulouse, France
[4] Univ Toulouse III Paul Sabatier, INSERM, IFERISS, Toulouse, France
来源
LANCET PUBLIC HEALTH | 2022年 / 7卷 / 03期
关键词
D O I
10.1016/S2468-2667(22)00007-X
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background Data on health inequalities related to the dynamic of SARS-CoV-2 infection in France are scarce. The aim of this study was to analyse the association between an area-based deprivation indicator and SARS-CoV-2 incidence, positivity, and testing rates between May 2020 and April 2021. Methods We analysed data reported to the Systeme d'Information de Depistage Populationnel surveillance system between May 14, 2020 and April 29, 2021, which records the results of all SARS-CoV-2 tests in France. Residential addresses of tested individuals were geocoded to retrieve the associated aggregated units for the statistical information (IRIS) scale, corresponding to an area comprising 2000 inhabitants relatively homogenous in terms of socioeconomic characteristics. A social deprivation score was assigned to each area using the European Deprivation Index (EDI). We fitted negative binomial generalised additive models to model the age-standardised and sex-standardised ratios for SARS-CoV-2 incidence, positivity rates, and testing rates, and to estimate incidence rate ratios (IRRs) and 95% CIs of their association with EDI quintiles, using the first quintile (least deprived) as the reference category, adjusted for week, population density, and region. Findings Analyses were based on 70 990 478 SARS-CoV-2 tests, of which 5 000 972 were positive. SARS-CoV-2 incidence was higher in the most deprived areas than the least deprived areas (IRR 1middot148 [95% CI 1middot138-1middot158]) and positivity rates were also higher (IRR 1middot283 [1middot273-1middot294]), whereas testing rates were lower in the most deprived areas than the least deprived areas (IRR 0middot905 [0middot904-0middot907]). SARS-CoV-2 incidence and positivity rates remained higher in the most deprived areas than the least deprived areas during the second and third national lockdowns, and variation in testing rate was observed according to population density. Interpretation Our results highlight a positive social gradient between deprivation and the risk of testing positive for SARS-CoV-2, with the highest risk among individuals living in the most deprived areas and a negative social gradient for testing rate. These findings might reflect structural barriers to health-care access in France and lower capacity of deprived populations to benefit from protective measures. Funding None. Copyright (c) 2022 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license.
引用
收藏
页码:E240 / E249
页数:10
相关论文
共 50 条
  • [1] The effect of social deprivation on the dynamic of the SARS-CoV-2 infection in France
    Smaili, S.
    Pelat, C.
    Chatignoux, E.
    Kelly-Irving, M.
    Delpierre, C.
    Vandentorren, S.
    EUROPEAN JOURNAL OF PUBLIC HEALTH, 2022, 32 : III457 - III457
  • [2] Social deprivation and SARS-CoV-2 testing: a population-based analysis in a highly contrasted southern France region
    Landier, Jordi
    Bassez, Lea
    Bendiane, Marc-Karim
    Chaud, Pascal
    Franke, Florian
    Nauleau, Steve
    Danjou, Fabrice
    Malfait, Philippe
    Rebaudet, Stanislas
    Gaudart, Jean
    FRONTIERS IN PUBLIC HEALTH, 2023, 11
  • [3] SARS-CoV-2 Infection in Cancer Patients: A Population-Based Study
    Zorzi, Manuel
    Guzzinati, Stefano
    Avossa, Francesco
    Fedeli, Ugo
    Calcinotto, Arianna
    Rugge, Massimo
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [4] Population-based data on risks of SARS-CoV-2 infection in pregnancy
    Klein, Friederike
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2023, 83 (06) : 630 - 630
  • [5] Population-based sero-epidemiological investigation of SARS-CoV-2 infection in Somalia
    Hossain, Md Shajib
    Derrow, Mohamed Mohamud
    Mohamed, Sahra Isse
    Abukar, Hasan Mukhtar
    Qayad, Mohamed G.
    Malik, Sk Md Mamunur Rahman
    Mengistu, Kumlachew Fikremariam
    Obsie, Ali Abdilahi Ali
    Anwar, Iqbal
    JOURNAL OF INFECTION AND PUBLIC HEALTH, 2023, 16 (06) : 948 - 954
  • [6] Severe SARS-CoV-2 infection as a marker of undiagnosed cancer: a population-based study
    Adeline Dugerdil
    Laura Semenzato
    Alain Weill
    Mahmoud Zureik
    Antoine Flahault
    Scientific Reports, 13
  • [7] INDIVIDUAL, HOUSEHOLD AND NEIGHBOURHOOD FACTORS IN SARS-CoV-2 INFECTION: A POPULATION-BASED STUDY
    Costa, J. P.
    Ribeiro, A. I.
    Severo, M.
    Guimaraes, J. T.
    Ramos, A.
    Henriques, A.
    Meireles, P.
    Barros, H.
    GACETA SANITARIA, 2023, 37 : S279 - S279
  • [8] Severe SARS-CoV-2 infection as a marker of undiagnosed cancer: a population-based study
    Dugerdil, Adeline
    Semenzato, Laura
    Weill, Alain
    Zureik, Mahmoud
    Flahault, Antoine
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [9] Population-based study of the durability of humoral immunity after SARS-CoV-2 infection
    Peterhoff, David
    Wiegrebe, Simon
    Einhauser, Sebastian
    Patt, Arisha J.
    Beileke, Stephanie
    Guenther, Felix
    Steininger, Philipp
    Niller, Hans H.
    Burkhardt, Ralph
    Kuechenhoff, Helmut
    Gefeller, Olaf
    Ueberla, Klaus
    Heid, Iris M.
    Wagner, Ralf
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [10] Androgen-deprivation therapies for prostate cancer and risk of infection by SARS-CoV-2: a population-based study (N=4532)
    Montopoli, M.
    Zumerle, S.
    Vettor, R.
    Rugge, M.
    Zorzi, M.
    Catapano, C., V
    Carbone, G. M.
    Cavalli, A.
    Pagano, F.
    Ragazzi, E.
    Prayer-Galetti, T.
    Alimonti, A.
    ANNALS OF ONCOLOGY, 2020, 31 (08) : 1040 - 1045